MedTrace Logo

Access BNP Clinical Enrollment Study

NCT06624293 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2025-04-23

No results posted yet for this study

Summary

The goal of this study is to collect blood from subjects with a suspicion of either new onset or worsened heart failure to be used for testing studies for a new product to aid in the diagnosis of heart failure.

Conditions

Interventions

DIAGNOSTIC_TEST

BNP

Blood collected during this study will be tested on separate IUO BNP assay on a separate protocol. No active interventions will occur during this study.

Sponsors & Collaborators

  • Beckman Coulter, Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-30
Primary Completion
2025-02-18
Completion
2025-02-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06624293 on ClinicalTrials.gov